Raymond James analyst Simon Leopold resumed coverage of Astera Labs (ALAB) with a Market Perform rating and no price target The company is well positioned to benefit from generative artificial intelligence trends but the shares are fairly valued, the analyst tells investors in a research note. The firm sees long-term structural challenges for Astera.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALAB:
- Midday Fly By: Nvidia reports Q3 beat, Abbott buys Exact Sciences
- Astera initiated, Nasdaq upgraded: Wall Street’s top analyst calls
- 3 Best Stocks to Buy Now, 11/20/2025, According to Top Analysts
- Astera Labs initiated with an Outperform at BNP Paribas Exane
- Astera Labs upgraded to Outperform from Market Perform at Northland